Company Quest PharmaTech Inc. Other OTC

Stocks

QPTFF

CA74836M1068

Biotechnology & Medical Research

Business description: Quest PharmaTech Inc.

Sales by Activity: Quest PharmaTech Inc.

Executive Committee: Quest PharmaTech Inc.

Composition of the Board of Directors: Quest PharmaTech Inc.

Shareholders: Quest PharmaTech Inc.

Company details: Quest PharmaTech Inc.

Other Biotechnology & Medical Research

Sector

Inactive Instrument

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuestâ€™s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.

Fiscal Period: January	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)	2026 (CAD)

See all business segments

Manager	Title	Age	Since
Ragupathy Madiyalakan CEO	Chief Executive Officer	-	16/06/2004
Pierre Vermette DFI	Director of Finance/CFO	-	31/12/2004

See QUEST PHARMATECH INC. governance

Director	Title	Age	Since
Ragupathy Madiyalakan BRD	Director/Board Member	-	16/06/2004
J. Lievonen CHM	Chairman	-	04/07/2021
Jeffrey Shon BRD	Director/Board Member	-	04/07/2021
Bradley J Glass BRD	Director/Board Member	-	-

Composition of the Board of Directors

Name	Stocks	%	Valuation
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. 14.78 %	25,000,000	14.78 %	350 000 $
Ragupathy Madiyalakan 1.892 %	3,200,000	1.892 %	44 800 $
Pierre Vermette 1.042 %	1,761,518	1.042 %	24 661 $
Jeffrey Shon 0.2069 %	350,000	0.2069 %	4 900 $
J. Lievonen 0 %	0	0 %	- $

List of QUEST PHARMATECH INC. shareholders

Quest PharmaTech, Inc.

97 Street NW

T6E 5R9, Edmonton

http://www.questpharmatech.com

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+1.14%	+2.27%	+2.38%	+24.14%	50.5B
REVOLUTION MEDICINES, INC.	-1.36%	+4.82%	+485.55%	+614.84%	46.01B
BEONE MEDICINES AG	-2.04%	+3.69%	+19.34%	+91.23%	42.85B
IQVIA HOLDINGS INC.	+2.72%	+6.02%	+33.33%	+19.66%	41.03B
CELLTRION, INC.	0.00%	-3.91%	+18.49%	+47.98%	32.02B
MEDPACE HOLDINGS, INC.	+0.72%	+5.27%	+31.55%	+145.37%	16.98B
ASCENDIS PHARMA A/S	-1.85%	+3.48%	-	-	17.05B
EUROFINS SCIENTIFIC SE	+3.06%	+3.88%	+5.81%	+35.00%	14.3B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+0.50%	+3.62%	+82.64%	+46.53%	13.84B
Average	+0.32%	+2.92%	+84.89%	+128.09%	30.51B
Weighted average by Cap.	+0.18%	+2.74%	+104.88%	+152.88%

See all sector performances

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research